Protective T-cell memory has long been thought to reside in blood and lymph nodes, but recently the concept of immune memory in peripheral tissues mediated by resident memory T (T RM ) cells has been proposed 1-5 . Here we show in mice that localized vaccinia virus (VACV) skin infection generates long-lived non-recirculating CD8 1 skin T RM cells that reside within the entire skin. These skin T RM cells are potent effector cells, and are superior to circulating central memory T (T CM ) cells at providing rapid long-term protection against cutaneous re-infection. We find that CD8 1 T cells are rapidly recruited to skin after acute VACV infection. CD8 1 T-cell recruitment to skin is independent of CD4 1 T cells and interferon-c, but requires the expression of E-and P-selectin ligands by CD8 1 T cells. Using parabiotic mice, we further show that circulating CD8 1 T CM and CD8 1 skin T RM cells are both generated after skin infection; however, CD8 1 T CM cells recirculate between blood and lymph nodes whereas T RM cells remain in the skin. Cutaneous CD8 1 T RM cells produce effector cytokines and persist for at least 6 months after infection. Mice with CD8 1 skin T RM cells rapidly cleared a subsequent re-infection with VACV whereas mice with circulating T CM but no skin T RM cells showed greatly impaired viral clearance, indicating that T RM cells provide superior protection. Finally, we show that T RM cells generated as a result of localized VACV skin infection reside not only in the site of infection, but also populate the entire skin surface and remain present for many months. Repeated re-infections lead to progressive accumulation of highly protective T RM cells in non-involved skin. These findings have important implications for our understanding of protective immune memory at epithelial interfaces with the environment, and suggest novel strategies for vaccines that protect against tissue tropic organisms.
Protective T-cell memory has long been thought to reside in blood and lymph nodes, but recently the concept of immune memory in peripheral tissues mediated by resident memory T (T RM ) cells has been proposed [1] [2] [3] [4] [5] . Here we show in mice that localized vaccinia virus (VACV) skin infection generates long-lived non-recirculating CD8 1 skin T RM cells that reside within the entire skin. These skin T RM cells are potent effector cells, and are superior to circulating central memory T (T CM ) cells at providing rapid long-term protection against cutaneous re-infection. We find that CD8 1 T cells are rapidly recruited to skin after acute VACV infection. CD8 1 T-cell recruitment to skin is independent of CD4 1 T cells and interferon-c, but requires the expression of E-and P-selectin ligands by CD8 1 T cells. Using parabiotic mice, we further show that circulating CD8 1 T CM and CD8 1 skin T RM cells are both generated after skin infection; however, CD8 1 T CM cells recirculate between blood and lymph nodes whereas T RM cells remain in the skin. Cutaneous CD8 1 T RM cells produce effector cytokines and persist for at least 6 months after infection. Mice with CD8 1 skin T RM cells rapidly cleared a subsequent re-infection with VACV whereas mice with circulating T CM but no skin T RM cells showed greatly impaired viral clearance, indicating that T RM cells provide superior protection. Finally, we show that T RM cells generated as a result of localized VACV skin infection reside not only in the site of infection, but also populate the entire skin surface and remain present for many months. Repeated re-infections lead to progressive accumulation of highly protective T RM cells in non-involved skin. These findings have important implications for our understanding of protective immune memory at epithelial interfaces with the environment, and suggest novel strategies for vaccines that protect against tissue tropic organisms.
CD8 1 T cells have a pivotal role in antiviral immunity in target tissues [6] [7] [8] [9] . We infected the skin of control, CD4 2/2 , or CD4 1 T-celldepleted mice with VACV and assessed VACV-specific pentamer 1 CD8 1 T cells 10 . Absence of CD4 1 T cells did not impair either antigenspecific CD8 1 T-cell proliferation in draining lymph nodes or subsequent accumulation in skin; in fact, the latter was enhanced ( Fig. 1a , b). We then infected mice infused with OT-I (CD8 1 ) and OT-II (CD4 1 ) T cells with an ovalbumin-expressing VACV (VACV-Ova) 11 . OT-I T cells are a transgenic CD8 1 T-cell population that recognize ovalbumin residues 257-264 in the context of H-2K b , whereas OT-II T cells are a transgenic CD4 1 T-cell population recognizing ovalbumin residues 323-339 in the context of I-A b (ref. 1). After skin infection, both OT-I and OT-II cells proliferated similarly in draining lymph nodes, and OT-I cells but not OT-II cells accumulated significantly in infected skin (although other CD4 1 T cells showed some accumulation) ( Supplementary Fig. 1 and Fig. 1c, d ). Interestingly, OT-I cells accumulated in infected skin efficiently in the absence of either CD4 1 T cells or interferon (IFN)-c ( Fig. 1e, f) , in contrast to a recently reported herpes simplex virus (HSV) vaginal infection model 12 . However, skin accumulation (but not lymph-node proliferation) of OT-I cells from FucT IV/VII 2/2 mice, which cannot make E-and P-selectin ligands, was significantly impaired ( Fig. 1g and Supplementary Fig. 2a ). Both E-and P-selectin were significantly upregulated in VACV-infected skin ( Supplementary Fig. 2b ). Thus, CD8 1 T-cell accumulation in skin after VACV infection does not require CD4 1 T cells or IFN-c, but does require expression of E-and P-selectin ligands.
Murine models of viral infections of skin and other tissues have been useful in the study of T-cell memory [13] [14] [15] [16] . We explored the ability of CD8 1 memory T cells generated by VACV infection to recirculate after resolution of the cutaneous infection. We infected the skin of mice infused with OT-I cells with VACV, and waited until complete resolution of the infection (30 days). At 30 days we could identify T CM cells in lymph nodes and effector memory T (T EM ) cells in skin ( Supplementary Fig. 3a, b ). We then surgically created parabiotic pairs between the infected mice and never-infected naive mice that had not been given OT-I cells. Parabiotic pairs were maintained for 2, 4, 8, 12 and 24 weeks, at which point they were surgically separated for the analysis of VACV-specific OT-I T cells ( Fig. 2a ). Mice joined for 8 weeks had similar numbers of OT-I T CM cells in the spleen and lymph nodes of both parabionts, indicating rapid recirculation and equilibration of T CM cells ( Fig. 2b, d ). However, at 2-24 weeks there were no OT-I T RM cells in the skin of the unimmunized parabiont ( Fig. 2c, e ). These early kinetics of T CM recirculation and T RM nonrecirculation were confirmed by parabiotic mice that received no OT-I cells, using pentamer expression to identify VACV-specific memory cells ( Supplementary Fig. 4 ). OT-I T RM cells were readily identified in the skin of previously infected parabionts and mice that had been infected in parallel but never joined. These OT-I T RM cells represented a significant fraction of total skin cells (Fig. 2c ), and persisted for long periods of time: 30% of skin CD8 1 T cells at 12 weeks, and 15-20% of skin CD8 1 T cells at 24 weeks. In contrast, naive mice joined to previously infected mice had no OT-I T RM cells in the skin, even after 24 weeks of parabiosis ( Fig. 2c, e ). Thus, skin T RM cells persisted in skin for at least 6 months after infection and did not recirculate appreciably. T RM and T CM cells were further analysed by fluorescence-activated cells sorting (FACS) for expression of CD69, CD103, E-and P-selectin ligands, and production of IFN-c and TNF-a upon activation. A subset of T RM cells expressed BCL2, and T RM cells lacked CD122 and CD127 ( Supplementary Fig. 5 ). Immunofluorescence staining showed that many T RM cells localize in epidermal and follicular epithelium, as reported in skin HSV infection 17 , but also localize in the dermis (Fig. 2f ).
To compare directly the ability of T CM and T RM cells to eliminate a subsequent VACV infectious challenge, we infused mMT mice with OT-I cells and infected them through the skin with VACV-Ova. After 30 days, mice were joined parabiotically to naive mMT mice for 8 weeks, and then surgically separated. 
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T CM cells in both the spleen and lymph nodes and T RM cells within the skin, whereas the uninfected parabiont contained T CM cells only in the spleen and lymph nodes (Fig. 2) . At 2 weeks after separation, the skin of these mice was challenged with VACV-Ova, and assessed 6 days later for viral load (Fig. 3a) . Despite the presence of abundant circulating OT-I T CM cells, uninfected parabionts cleared the virus only 30fold more effectively than naive mice (Fig. 3b) . In contrast, the infected parabiont cleared the virus completely, 10 4 -fold more effectively than the uninfected parabiont (Fig. 3b ). Viral clearance was efficient even in mice treated with FTY720, a S1P inhibitor that blocks egress of T CM cells from lymph nodes into blood 1 (Fig. 3b ). To show that this was not an artefact of OT-I cell transfer, we reproduced and extended the experiment in a parabiotic model not involving transfer of OT-I cells (Fig. 3c ). Parabiotic pairs were separated at 4 weeks, challenged with VACV, and assessed for viral load at 6, 14 and 26 days after challenge. There were again striking differences in the ability of endogenous T RM Fig. 2 . Eight weeks after surgery, parabiotic mice were separated. Two weeks later, separated mice were challenged with VACV-Ova on the skin. Half mice were injected daily with FTY720. b, Six days after challenge, skin viral load was assayed by quantitative polymerase chain reaction (qPCR). ctl, control; immu., immunized; nor., normal; para., parabiont. c, In separate experiments, mMT mice without OT-I transfer but with VACV skin infection were used to create immunized:unimmunized parabiotic mice. Four weeks after surgery, the same VACV skin challenge protocol was applied. d-f, Six, fourteen or twenty-six days after challenge, viral load was assayed. The results from duplicate qPCR runs are plotted. Horizontal bars indicate the mean. Data are representative of two independent experiments (n 5 5 mice per group). **P , 0.01; N.S., not significant; N.D., not detectable.
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and T CM cells to mediate viral clearance at days 6 ( Fig. 3d ) and 14 (Fig. 3e) , which began to normalize by day 26 (Fig. 3f ). However, FTY720-treated T CM mice (the parabiont containing T CM cells but no T RM cells) are unable to clear virus even 26 days after infection, a time point by which naive mice have cleared the skin infection (Fig. 3f) , presumably by generating protective T RM cells. Thus, although T CM cells are superior to naive T cells, they are inferior to T RM cells at mediating rapid viral clearance from skin. E-and P-selectin, CCL17 and ICAM1 are expressed constitutively on the blood vessels of normal skin [18] [19] [20] and can support entry into uninflamed skin of T EM cells generated by cutaneous VACV infection.
To study this phenomenon, we infected the left ears of OT-I-loaded mice with VACV-Ova and then measured the accumulation of OT-I cells in both infected (left) and uninfected (right) ears. There was measurable accumulation of OT-I cells in both ears, with similar kinetics. The absolute number of OT-I cells was always higher in the infected ear, but even 30 days after infection, OT-I cells represented a measurable fraction of all cells present in the uninfected ear (Fig. 4a) . Thus, VACV skin infection generates CD8 1 T RM cells that distribute to distant skin sites as well as the site of infection. The accumulation of OT-I T RM cells in distant skin sites is increased further after multiple sequential infections to other sites of skin ( Fig. 4b-d ), suggesting that skin T RM cells continue to accumulate throughout skin in response to repeated cutaneous infections at distant sites.
To determine if CD8 1 T RM cells in distant skin sites were as protective as those at previously infected sites, we challenged mMT mice previously infected on one ear with a second VACV skin infection on both ears either 7 or 30 days after the initial infection. FYT720 was administered to limit the contribution of T CM cells (Fig. 4e) . Notably, at both day 7 and day 30, T RM cells in distant skin sites markedly reduced viral loads to levels comparable to those observed at the actual site of previous infection, indicating that these distant T RM cells were highly effective at rapidly eliminating virus. In contrast, viral loads in the skin of intraperitoneally (i.p.) immunized mice were between 10 3 and 10 4 higher at these time points (Fig. 4f, g) . Thus, skin infection with VACV generates populations of T EM cells that distribute to the entire skin surface, become T RM cells, and mediate protection of the skin against re-infection with VACV in the absence of antibodies or T CM cells.
T RM cells have now been identified in the skin, gut, lung and brain in murine models 1, [21] [22] [23] and human subjects in both health and in the setting of skin disease 2, 4, 5, 24, 25 . We demonstrate that after VACV viral infection through the skin, CD8 1 T RM cells are generated and distribute not only to the site of infection but also throughout the entire skin surface. These CD8 1 T RM cells produce effector cytokines, persist for many months, and are highly effective at rapidly controlling subsequent VACV skin infection. T RM cells were orders of magnitude more effective than T CM cells at controlling viral re-infection of the skin, at all time points examined in this study. The use of parabiotic mice allowed us to examine rigorously the tissue distribution and relative roles of T CM and T RM cells in VACV immune responses. The relatively minor role of CD4 1 T cells in VACV skin infection may reflect differences in immune responses to different viruses and/ or infection of different tissues, as CD4 1 T cells are clearly more important in HSV infection 12, 26 . Moreover, CD4 1 T RM cells predominate in human skin 24 and lung 25 , and are enriched for memory cells specific for pathogens encountered through those tissues 25, 27, 28 .
Pathogens typically invade the host through epithelial interfaces with the environment. Our studies suggest that T EM cells generated as a result of epithelial tissue infections accumulate as T RM cells at both sites of infection as well as at distant sites within the same epithelial tissue, providing broad and long-lived protective T-cell immunity against 
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re-infection. A more complete understanding of T RM -cell-mediated immune memory should enhance our understanding of adaptive immunological memory, influence rational vaccine design, and illuminate the pathophysiology of human T-cell-mediated diseases.
METHODS SUMMARY
VACV skin infection. 2 3 10 6 p.f.u. of recombinant VACV Western Reserve strain or VACV expressing full-length ovalbumin (VACV-Ova) was used for epicutaneous infection by skin scarification or i.p. injection, as described previously 29 . Parabiotic mice. Well-matched (sex and age) mouse partners were anaesthetized to full muscle relaxation with ketamine and xylazine (10 mg g 21 ) or 2.5% avertin (15 ml g 21 ) by i.p. injection. The corresponding lateral aspects of mice were shaved and the excess hair was wiped off with alcohol prep pad. The disinfection was performed by wiping with betadine solution and 70% ethanol three times. Matching skin incisions were made from the olecranon to the knee joint of each mouse, and the subcutaneous fascia was bluntly dissected to create about 0.5 cm of free skin. The olecranon and knee joints were attached by a single 5-0 silk suture and tie, and the dorsal and ventral skins were approximated by staples or continuous suture. Betadine solution was used to cover the full length of the dorsal and ventral incision. The mice were then kept on heating pads and continuously monitored until recovery. For analgesic treatment, mice were injected subcutaneously with 2.5 mg g 21 flunixin every 8-12 h for 48 h after the operation. Cell isolation from skin. Before harvest, skin hair was removed using Nair Hair Remover. Skin samples were then chopped into small fragments and incubated in Hanks balanced salt solution (HBSS) supplemented with 1 mg ml 21 collagenase A (Roche) and 40 mg ml 21 DNase I (Roche) at 37 uC for 30 min. After filtrating through a 70-mm nylon cell strainer, cells were collected and washed thoroughly with cold PBS before staining.
